Deep neural networks have significantly advanced medical image classification across various modalities and tasks. However, manually designing these networks is often time-consuming and suboptimal. Neural Architecture Search (NAS) automates this process, potentially finding more efficient and effective models. This study provides a comprehensive comparative analysis of our two NAS methods, PBC-NAS and BioNAS, across multiple biomedical image classification tasks using the MedMNIST dataset. Our experiments evaluate these methods based on classification performance (Accuracy (ACC) and Area Under the Curve (AUC)) and computational complexity (Floating Point Operation Counts). Results demonstrate that BioNAS models slightly outperform PBC-NAS models in accuracy, with BioNAS-2 achieving the highest average accuracy of 0.848. However, PBC-NAS models exhibit superior computational efficiency, with PBC-NAS-2 achieving the lowest average FLOPs of 0.82 GB. Both methods outperform state-of-the-art architectures like ResNet-18 and ResNet-50 and AutoML frameworks such as auto-sklearn, AutoKeras, and Google AutoML. Additionally, PBC-NAS and BioNAS outperform other NAS studies in average ACC results (except MSTF-NAS), and show highly competitive results in average AUC. We conduct extensive ablation studies to investigate the impact of architectural parameters, the effectiveness of fine-tuning, search space efficiency, and the discriminative performance of generated architectures. These studies reveal that larger filter sizes and specific numbers of stacks or modules enhance performance. Fine-tuning existing architectures can achieve nearly optimal results without separating NAS for each dataset. Furthermore, we analyze search space efficiency, uncovering patterns in frequently selected operations and architectural choices. This study highlights the strengths and efficiencies of PBC-NAS and BioNAS, providing valuable insights and guidance for future research and practical applications in biomedical image classification.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.artmed.2024.103064 | DOI Listing |
Alzheimers Dement
December 2024
Relecura, Bangalore, karnataka, India.
Background: Clinical Dementia Rating (CDR) and its evaluation have been important nowadays as its prevalence in older ages after 60 years. Early identification of dementia can help the world to take preventive measures as most of them are treatable. The cellular Automata (CA) framework is a powerful tool in analyzing brain dynamics and modeling the prognosis of Alzheimer's disease.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Weill Cornell Medicine, New York City, NY, USA.
Background: Early detection of Alzheimer's disease (AD) can improve prognosis, given new anti-amyloid therapies. Both positron emission tomography (PET) and magnetic resonance (MR) imaging biomarkers are currently used (1). 48F-Fluorodeoxyglucose-PET (FDG-PET) can detect neurodegeneration-related hypometabolism but is costly and not easily accessible (2).
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Pennsylvania, Philadelphia, PA, USA.
Background: Structural and functional heterogeneity in the brains of patients with Alzheimer's disease (AD) leads to diagnostic and prognostic uncertainty and confounds clinical treatment planning. Normative modelling, where individual-level deviations in brain measures from a reference sample are computed to infer personalized effects of disease, allows parsing of disease heterogeneity. In this study, GAN based normative modelling technique quantifies individual level neuroanatomical abnormality thereby facilitating measurement of personalized disease related effects in AD patients.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
UT Health San Antonio, San Antonio, TX, USA.
Background: Primary progressive aphasia (PPA) is a language-led dementia associated with underlying Alzheimer's disease (AD) or frontotemporal lobar degeneration pathology. As part of the Alzheimer's spectrum, logopenic (lv) PPA may be particularly difficult to distinguish from amnestic AD, due to overlapping clinical features. Analysis of linguistic and acoustic variables derived from connected speech has shown promise as a diagnostic tool for differentiating dementia subtypes.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Texas, Austin, TX, USA.
Background: Primary progressive aphasia (PPA) is a language-based dementia linked with underlying Alzheimer's disease (AD) or frontotemporal dementia. Clinicians often report difficulty differentiating between the logopenic (lv) and nonfluent/agrammatic (nfv) subtypes, as both variants present with disruptions to "fluency" yet for different underlying reasons. In English, acoustic and linguistic markers from connected speech samples have shown promise in machine learning (ML)-based differentiation of nfv from lv.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!